Results 131 to 140 of about 88,181 (222)

Vulva

, 2022
Peer ...
openaire   +1 more source

Making Sense of Erotically Oppressive Lifeworlds: Dynamics of Testimonial Smothering and Testimonial Quieting

Journal of Social Philosophy, EarlyView.
Paul Giladi
wiley   +1 more source

The Effectiveness of Medical Therapies for Joint, Skin and Eye Extraintestinal Manifestations in IBD—An Umbrella Review

Alimentary Pharmacology &Therapeutics, Volume 61, Issue 12, Page 1854-1871, June 2025.
Evidence for medical therapies targeting joint, skin and eye EIMs in IBD is heterogeneous and of low certainty. Multidisciplinary care and development of standardised, more appropriate outcome measures are essential to improve evaluation and guide future research. ABSTRACT Background Extraintestinal manifestations (EIMs) occur commonly in patients with
Olga M. Nardone, Nurulamin M. Noor, Aniruddh Prabhu, Alessandra Lim, Anirudh Krishnakumar, Abdulaziz Alajmi, Yuhong Yuan, Vipul Jairath, Maria Manuela Estevinho, Virginia Solitano   +9 more
wiley   +1 more source

Recurrent Aggressive Angiomyxoma That Responded to the Gonadotropin-Releasing Hormone (GnRH) Antagonist Relugolix. [PDF]

Cureus
Saito A, Komiyama S, Nagashima M, Kugimiya T, Mukai T.   +4 more
europepmc   +1 more source

Listening to Women's Voices: A Patient and Public Involvement Exercise Exploring Vulval Reconstructive Surgery for UK Women With Female Genital Mutilation (FGM)

Health Expectations, Volume 28, Issue 3, June 2025.
ABSTRACT Introduction This article presents patient and public involvement and engagement (PPIE) work undertaken to explore FGM survivors' and stakeholders' views on reconstructive surgery, potential service models, care pathways, barriers to access and other support needs.
Juliet Albert, Janet Fyle, Njomeza Kartallozi, Christie Coho, Naana Otoo‐Oyortey, Hekate Papadaki, Catrin Evans, Dalia Saidan, Sohier Elneil, Natasha Anderson‐Foster, Jasmine Abdulcadir, Huda Mohamed, Aurora Almadori   +12 more
wiley   +1 more source

Myoepithelioma-Like Tumor of the Vulva. [PDF]

Case Rep Pathol
Ma J, Meng Q, Chen F, Wei J.
europepmc   +1 more source

Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study

Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 6, Page 1152-1162, June 2025.
ALLEGRO‐LT (NCT04006457) is an open‐label, phase 3 study investigating the long‐term safety and efficacy of ritlecitinib in patients with alopecia areata (AA). In this analysis in 449 de novo patients with AA and ≥25% scalp hair loss, ritlecitinib demonstrated clinical efficacy and had an acceptable safety profile through Month 24.
C. Tziotzios, R. Sinclair, A. Lesiak, S. Mehlis, M. Kinoshita‐Ise, A. Tsianakas, X. Luo, E. H. Law, R. Ishowo‐Adejumo, R. Wolk, M. Sadrarhami, A. Lejeune   +11 more
wiley   +1 more source

Association between contextual factors and vulvovaginal symptoms in Brazilian women: A cross-sectional study. [PDF]

Braz J Phys Ther
de Araujo Silva CM, Sato TO, de Sousa VPS, Pereira ND, Rodrigues-de-Souza DP, Beleza ACS.   +5 more
europepmc   +1 more source

Cancer of the vulva [PDF]

Cancer, 1961
Neal L. Ross, James A. Merrill
openaire   +3 more sources

Symptom Experience After Surgical Treatment for Vulvar Cancer—A Scoping Review

Scandinavian Journal of Caring Sciences, Volume 39, Issue 2, June 2025.
ABSTRACT Background Previous reviews have indicated a high burden of physical, emotional and sexual symptoms in women who have undergone surgery for vulvar cancer. Numerous surgical modifications have been made over the past few decades to limit post‐operative symptoms.
Anne Marie Thimm, Eva Helena Hansson, Katrine Bak Wraae, Mette Linnet Olesen   +3 more
wiley   +1 more source